301.39
BATS BZX Real-Time Price
As of 12:32pm ET
 +0.17 / +0.06%
Today’s Change
201.91
Today|||52-Week Range
317.72
+17.09%
Year-to-Date

Today’s Trading

Previous close301.22
Today’s open300.52
Day’s range299.99 - 303.71
Volume1,354,197
Average volume (3 months)3,189,116
Market cap$118.3B
Dividend yield--
Data as of 12:17pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+27.70%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.83

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.49-0.71%
NVONovo Nordisk-0.18-0.31%
GSKGlaxoSmithKline-0.10-0.22%
ABBVAbbVie-0.09-0.14%
Data as of 12:32pm ET, 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)$4.26
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers